Non-Coding Rnas and Exosomal Non-Coding Rnas in Pituitary Adenoma Publisher Pubmed



Rahimian N^{1, 2} ; Sheida A^{3, 4} ; Rajabi M⁵ ; Heidari MM^{4, 6} ; Tobeiha M^{3, 4} ; Esfahani PV^{3, 4} ; Ahmadi Asouri S⁷ ; Hamblin MR⁸ ; Mohamadzadeh O⁹ ; Motamedzadeh A¹⁰ ; Khaksary Mahabady M¹¹ Show Affiliations
Source: Pathology Research and Practice Published:2023

Abstract

Pituitary adenoma (PA) is the third most common primary intracranial tumor in terms of overall disease incidence. Although they are benign tumors, they can have a variety of clinical symptoms, but are mostly asymptomatic, which often leads to diagnosis at an advanced stage when surgical intervention is ineffective. Earlier identification of PA could reduce morbidity and allow better clinical management of the affected patients. Non-coding RNAs (ncRNAs) do not generally code for proteins, but can modulate biological processes at the post-transcriptional level through a variety of molecular mechanisms. An increased number of ncRNA expression profiles have been found in PAs. Therefore, understanding the expression patterns of different ncRNAs could be a promising method for developing non-invasive biomarkers. This review summarizes the expression patterns of dysregulated ncRNAs (microRNAs, long non-coding RNAs, and circular RNAs) involved in PA, which could one day serve as innovative biomarkers or therapeutic targets for the treatment of this neoplasia. We also discuss the potential molecular pathways by which the dysregulated ncRNAs could cause PA and affect its progression. © 2023 Elsevier GmbH